Neurology Today in 5

American Academy of Neurology
  • 4.6 (21)
  • MEDICINE
  • UPDATED SEMIMONTHLY

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.

  1. 2D AGO

    Lasmiditan Discontinuation, DAAN Designation, Alteplase for Eye Stroke

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke.

    5 min

  2. JAN 15

    Genetic Counselors, Wrist-Worn Stimulation Device for Essential Tremor, CREST-2 Study Results

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the growing role of genetic counselors in neurology, a wrist-worn stimulation device for essential tremor, and results from the CREST-2 study of asymptomatic carotid disease.

    5 min

  3. JAN 2

    Shunt Benefit in iNPH, Downstream Revenue, Anticoagulant Monotherapy

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the benefit of shunts in idiopathic normal-pressure hydrocephalus, how neurologists drive downstream revenue, and anticoagulant monotherapy after stroke.

    5 min

  4. 12/18/2025

    P-tau217 Alzheimer's Blood Test, Tirofiban With Thrombolysis, Artificial Intelligence in Diagnostic Coding

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a p-tau217 blood test for Alzheimer's disease, the benefits of tirofiban with thrombolysis, and an AI tool that excels in diagnostic coding.

    5 min

  5. 12/04/2025

    Medical school acceptance, hemorrhagic stroke surgery, brain tumors after TBI

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about medical school acceptance rates after the ending of affirmative action, minimally invasive surgery for hemorrhagic stroke, and the increased risk of brain tumors after traumatic brain injury.

    5 min

  6. 11/20/2025

    Artificial sweeteners cognition concerns, drug company payments and prescribing decisions, graphene technology

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about artificial sweeteners' impact on cognitive health, how drug company payments influence prescribing decisions, and the use of graphene technology to accelerate maturation of neurons.

    5 min

  7. 11/06/2025

    50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about how monoclonal antibodies revolutionized neurologic treatment, why pregabalin link to increased heart failure, and a combined therapy that slows progression in primary progressive aphasia.

    4 min

  8. 10/16/2025

    Novel PET radiotracer, GLP-1s and dementia risk, green space benefits

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a PET radiotracer that shows intranasally delivered insulin enters the brain, GLP-1s and dementia risk in people with Type 2 diabetes, and how exposure to green space may reduce the risk of neurodevelopmental delays in children.

    5 min
See All (99)

Ratings & Reviews

4.6
out of 5
21 Ratings

About

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.

Information

  • Creator
    American Academy of Neurology
  • Years Active
    2018 - 2026
  • Episodes
    99
  • Rating
    Clean
  • Copyright
    © 2024
  • Show Website
    Neurology Today in 5

You Might Also Like